Physician profile
Nishant Gupta
NPI 1598010910
$1,752.72
in general payments reported to CMS, 2019-2025
4 companies · $1,491 in 2025
The $1,491 reported for 2025 was more than what 88% of Diagnostic Radiology providers received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $36.59 · 2023: $179 · 2024: $46.04 · 2025: $1,491.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,138 · Food and Beverage: $578.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,138.33 |
| Food and Beverage | $577.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Telix Pharmaceuticals | $1,491.38 | 2025 | Illuccix |
| Medtronic, INC. | $178.71 | 2023 | Corevalve Evolut R |
| Boehringer Ingelheim Pharmaceuticals, INC. | $46.04 | 2024 | |
| Merck Sharp & Dohme LLC | $36.59 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nishant Gupta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.